Business Description
Gain Therapeutics is a biotechnology company founded in 2017 and headquartered in Bethesda, Maryland, with operations spanning Switzerland, Spain, and Australia. The company uses its proprietary drug discovery platform to identify new binding sites on disease-related proteins and develop small molecule treatments that target the root causes of serious conditions. Its lead compound is currently being tested in a clinical study for Parkinson's disease, while several other candidates are in earlier stages of development targeting diseases such as Alzheimer's, Gaucher's disease, and certain cancers.
